GF SEC(01776) plans to issue short-term corporate bonds of up to 3 billion yuan
Guangfa Securities (01776) announced that the company intends to issue Guangfa Securities Co., Ltd. 2026 short-term corporate bonds (first tranche) to professional investors from January 22, 2026 to January 23, 2026. The bond will be abbreviated as "26 Guangfa D1" with the bond code "524639". The issuance size will not exceed RMB 3 billion, with a maturity period of 365 days. The net proceeds will be used to repay the maturing short-term corporate bonds.
GF SEC (01776) announced that the company plans to issue GF SEC Corporation Limited 2026 short-term corporate bonds (first tranche) for professional investors from January 22, 2026 to January 23, 2026. The bond abbreviation is "26 GF D1" and the bond code is "524639". The issuance size will not exceed RMB 3 billion, with a maturity period of 365 days. The net proceeds from the fundraising will be used to repay short-term corporate bonds that are due.
Related Articles
KOS INTL (08042) is planning to change its name to "KOS INTL Talent Group Limited Company".
EXTRAWELL PHAR(00858): Yang Xiaorong appointed as an independent non-executive director.
GlaxoSmithKline plc Sponsored ADR (GSK.US) acquired RAPT Therapeutics (RAPT.US) for a valuation of $2.2 billion, causing a significant increase in pre-market trading.
KOS INTL (08042) is planning to change its name to "KOS INTL Talent Group Limited Company".
EXTRAWELL PHAR(00858): Yang Xiaorong appointed as an independent non-executive director.
GlaxoSmithKline plc Sponsored ADR (GSK.US) acquired RAPT Therapeutics (RAPT.US) for a valuation of $2.2 billion, causing a significant increase in pre-market trading.
